influenza vaccine

Also found in: Encyclopedia, Wikipedia.

influenza vaccine (nasal)

(in-floo-en-za vak-seen) ,


(trade name)


Therapeutic: vaccines immunizing agents
Pregnancy Category: C


Active live immunization for prevention of disease caused by Influenza A and B.


Active immunization with live virus produces antibodies against Influenza.

Therapeutic effects

Decreased influenzal illness, with fewer days lost from school or work.


Absorption: Virus replicates in nasopharynx causing production of antibodies.
Distribution: Unknown.
Metabolism and Excretion: Unknown.
Half-life: Unknown.

Time/action profile



Contraindicated in: Obstetric: Pregnancy; Hypersensitivity to FluMist, eggs, or egg products; History of asthma or reactive airways disease; Other live vaccine within 1 mo or inactivated vaccine within 2 weeks; Concurrent immunosuppressive therapy or disease causing immunosuppression or immunocompromise; Antiviral agents (not for 48 hr prior or 2 wk after); Pediatric: Children or adolescents (5–17 yr) receiving aspirin, aspirin-containing or salicylate therapy (risk of Reye syndrome); Chronic illness including cardiac/pulmonary disease, metabolic disease, renal impairment or hemoglobinopathy; History of Guillain-Barré.
Use Cautiously in: Obstetric / Pediatric: Lactation, children <2 yr, patients >50 yr (safety not established).

Adverse Reactions/Side Effects

Central nervous system

  • headache

Ear, Eye, Nose, Throat

  • rhinitis
  • nasal congestion


  • fever


Drug-Drug interaction

Concurrent use of aspirin or salicylates in children/adolescents may ↑ risk of Reye syndrome.Concurrent antiviral therapy (may affect desired immune response to FluMist).


Intranasal (Adults and Children 9–49 yr) One dose (0.5 mL)/season.
Intranasal (Children 2–8 yr) Previously immunized with FluMist—one dose (0.2 mL)/season; not previously immunized with FluMist—two doses (0.2 mL each)/30 days apart for initial season.


Pre-filled single-use intranasal sprayer: 0.5 mL/sprayer, 0.2 mL/sprayer

Nursing implications

Nursing assessment

  • Assess patient for history of asthma or reactive airway disease. Patients with positive history should not receive FluMist.
  • Lab Test Considerations: Monitor patient for signs of allergic reaction (rash, pruritus, laryngeal edema, wheezing) following administration. Keep epinephrine, an antihistamine, and resuscitation equipment close by in case of an anaphylactic reaction.

Potential Nursing Diagnoses

Deficient knowledge, related to medication regimen (Patient/Family Teaching)


  • Do not administer rimantidine or other antiviral agents within 48 hrs before or 2 wks after administration intranasal influenza virus vaccine (FluMist).
  • Store solution in refrigerator until just before use; do not freeze. Solution should be colorless to pale yellow and clear to slightly cloudy.
    • Do not administer FluMist concurrently with other vaccines, or in patients who have received a live virus vaccine within 1 mo or an inactivated vaccine within 2 wks of vaccination.
  • Intranasal: With the patient in an upright position, approximately 0.25 mL (half the dose of a single FluMist sprayer) is administered into each nostril. Insert the tip of the sprayer just inside the nostril and depress the plunger to spray. Remove the dose divider clip and administer the second half of the dose into the other nostril. Dispose of sprayer in routine for biohazard disposal.

Patient/Family Teaching

  • Explain to patient and parent the purpose of the vaccination.
  • Advise patient to avoid contact with patients who are immunocompromised for at least 21 days.

Evaluation/Desired Outcomes

  • Prevention of influenza resulting in fewer lost days from work and school.
Drug Guide, © 2015 Farlex and Partners

influenza vaccine

Flu vaccine A vaccine recommended for those at high risk for serious complications from influenza: > age 65; Pts with chronic diseases of heart, lung or kidneys, DM, immunosuppression, severe anemia, nursing home and other chronic-care residents, children and teenagers taking aspirin therapy–and who may thus be at risk for developing Reye syndrome after influenza infection, and those in close or frequent contact with anyone at high risk; persons with egg allergy should not receive IV. See Influenza, Vaccine.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
M2 PRESSWIRE-August 30, 2019-: Seasonal Influenza Vaccines Market Growth Rate, Manufacturers, Market Dynamics, Market Overview
Antibody Responses Against Heterologous H5N1 Strains for an MF59-Adjuvanted Cell Culture-Derived H5N1 (aH5N1c) Influenza Vaccine in Healthy Pediatric Subjects (E.
Seven reports detailed that patients were offered revaccination with the current season's influenza vaccine; of these, three confirmed revaccination.
A trivalent version of the Afluria influenza vaccine also now is indicated for people aged 6 months and up, according to a communication from the FDA.
Influenza vaccine supplier Seqirus revealed on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) for AFLURIA QUADRIVALENT (Influenza Vaccine) for use in people six months of age and older as well as the trivalent formulation of AFLURIA (Influenza Vaccine).
After 2 years of recommending against the use of live attenuated influenza vaccine (LAIV) because of its low effectiveness in children against influenza A (H1N1), ACIP now includes it as an option for the upcoming season in individuals ages 2 through 49 years.
Speaking on the issue of developing a cost-effective and affordable influenza vaccine rapidly without compromising its quality, Ambassador of the European Union H.E.
However, because influenza vaccines offer varying and sometimes limited protection, scientists are exploring ways to improve vaccine effectiveness.
Through the acquisition, Sanofi Pasteur, the vaccines global business unit of Sanofi, adds a product, Flublok (Influenza Vaccine), to its influenza vaccine portfolio.
The influenza vaccine, which is colloquially referred to as the "flu shot," is recommended as an annual part of preventive care for people who are [greater tahn or equal to]6 months of age (United States Government of Health and Human Services, 2015; Centers for Diseases Control and Prevention [CDC], 2016a; World Health Organization [WHO], 2016).
With increasing pandemic as well as seasonal outbreak and rising awareness among people about these vaccines, the Indian influenza vaccine market is poised to scale newer acmes.